Clinical trial
ApoB48IC2 Metabolism in Plasma and Interstitial Fluid
NCT03921203 is registered in ClinicalTrials.gov with Karolinska University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- ApoB48IC2 Metabolism in Plasma and Interstitial Fluid
- Lead sponsor
- Karolinska University Hospital
- Phase
- Observational
- Overall status
- Completed
- Start date
- April 17, 2019
- Completion date
- December 31, 2022
- Enrollment
- 22 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.